Mckinley Capital Management Has Cut By $918,136 Its Astrazeneca Plc (AZN) Holding; Freeport-mcmoran (FCX) Shorts Down By 3.77%

May 25, 2018 - By Stephen Andrade

Freeport-McMoRan Inc. (NYSE:FCX) Logo

Freeport-mcmoran Inc (NYSE:FCX) had a decrease of 3.77% in short interest. FCX’s SI was 31.90 million shares in May as released by FINRA. Its down 3.77% from 33.15M shares previously. With 15.79 million avg volume, 2 days are for Freeport-mcmoran Inc (NYSE:FCX)’s short sellers to cover FCX’s short positions. The SI to Freeport-mcmoran Inc’s float is 2.35%. The stock decreased 1.61% or $0.28 during the last trading session, reaching $17.1. About 4.03M shares traded. Freeport-McMoRan Inc. (NYSE:FCX) has risen 41.20% since May 25, 2017 and is uptrending. It has outperformed by 29.65% the S&P500.

Mckinley Capital Management Inc decreased Astrazeneca Plc (AZN) stake by 52.41% reported in 2017Q4 SEC filing. Mckinley Capital Management Inc sold 27,004 shares as Astrazeneca Plc (AZN)’s stock rose 3.15%. The Mckinley Capital Management Inc holds 24,524 shares with $851,000 value, down from 51,528 last quarter. Astrazeneca Plc now has $93.28B valuation. The stock increased 0.26% or $0.0941 during the last trading session, reaching $36.9741. About 3.55 million shares traded. AstraZeneca PLC (NYSE:AZN) has risen 9.03% since May 25, 2017 and is uptrending. It has underperformed by 2.52% the S&P500.

Investors sentiment decreased to 0.92 in 2017 Q4. Its down 0.08, from 1 in 2017Q3. It dropped, as 77 investors sold Freeport-McMoRan Inc. shares while 205 reduced holdings. 78 funds opened positions while 182 raised stakes. 989.88 million shares or 2.99% more from 961.13 million shares in 2017Q3 were reported. Dimensional Fund Advsrs L P owns 0.11% invested in Freeport-McMoRan Inc. (NYSE:FCX) for 14.02M shares. Fire Grp Incorporated stated it has 0.06% in Freeport-McMoRan Inc. (NYSE:FCX). Colorado-based Advisors Asset Mngmt has invested 0.01% in Freeport-McMoRan Inc. (NYSE:FCX). Engineers Gate Manager Lp accumulated 22,429 shares. Bennicas & Associate has invested 0.17% in Freeport-McMoRan Inc. (NYSE:FCX). Systematic Financial Mgmt Lp reported 142,964 shares. 32,140 were reported by Ntv Asset Mgmt Ltd Llc. Convergence Partners Llc has 0.38% invested in Freeport-McMoRan Inc. (NYSE:FCX). Parallax Volatility Advisers Lp, a California-based fund reported 31,440 shares. Private Advisor Grp Inc Ltd Liability Company has invested 0.02% of its portfolio in Freeport-McMoRan Inc. (NYSE:FCX). Guardian Capital Advisors Lp reported 0.08% in Freeport-McMoRan Inc. (NYSE:FCX). United Kingdom-based Gulf Intll State Bank (Uk) Ltd has invested 0.11% in Freeport-McMoRan Inc. (NYSE:FCX). Montgomery Investment Inc stated it has 1.67% in Freeport-McMoRan Inc. (NYSE:FCX). New Jersey Better Educational Savings Tru holds 0.27% or 14,000 shares. Glob X Mgmt Limited Co has invested 0.11% in Freeport-McMoRan Inc. (NYSE:FCX).

More notable recent Freeport-McMoRan Inc. (NYSE:FCX) news were published by: Seekingalpha.com which released: “Freeport-McMoRan Will Rebound” on May 03, 2018, also Seekingalpha.com with their article: “Freeport-McMoRan: Indonesian-Related Sell-Off” published on May 01, 2018, Bizjournals.com published: “Top of the pay grade: Here are the highest-paid CEOs in Phoenix” on May 25, 2018. More interesting news about Freeport-McMoRan Inc. (NYSE:FCX) were released by: Fool.com and their article: “Freeport-McMoRan Stock Upgraded: What You Need to Know” published on May 23, 2018 as well as Forbes.com‘s news article titled: “What Factors Have Led To Freeport’s Recent Stock Slump?” with publication date: May 18, 2018.

Freeport-McMoRan Inc. engages in the mining of mineral properties in the United States, Indonesia, Peru, and Chile. The company has market cap of $24.77 billion. It primarily explores for copper concentrate, copper cathode, copper rod, gold, molybdenum, silver, and other metals, as well as gas and oil. It has a 13.65 P/E ratio. The companyÂ’s portfolio of assets include the Grasberg minerals district in Indonesia; Morenci, Bagdad, Safford, Sierrita, and Miami in Arizona; Tyrone and Chino in New Mexico; and Henderson and Climax in Colorado, North America, as well as Cerro Verde and El Abra mines in South America.

Among 24 analysts covering Freeport-McMoran Copper & Gold (NYSE:FCX), 6 have Buy rating, 5 Sell and 13 Hold. Therefore 25% are positive. Freeport-McMoran Copper & Gold had 108 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was upgraded by S&P Research on Tuesday, September 1 to “Hold”. The firm earned “Hold” rating on Sunday, July 30 by RBC Capital Markets. RBC Capital Markets maintained the stock with “Sector Perform” rating in Tuesday, October 27 report. On Tuesday, April 19 the stock rating was downgraded by CLSA to “Sell”. Deutsche Bank downgraded it to “Hold” rating and $11 target in Monday, October 5 report. The stock of Freeport-McMoRan Inc. (NYSE:FCX) has “Sector Perform” rating given on Friday, September 25 by RBC Capital Markets. Bank of America maintained Freeport-McMoRan Inc. (NYSE:FCX) on Wednesday, October 4 with “Underperform” rating. As per Wednesday, June 28, the company rating was maintained by RBC Capital Markets. Jefferies maintained the shares of FCX in report on Monday, July 10 with “Buy” rating. Bank of America reinitiated the shares of FCX in report on Monday, October 17 with “Underperform” rating.

Since January 31, 2018, it had 0 buys, and 1 insider sale for $419,125 activity. The insider WHITMIRE C DONALD JR sold $419,125.

Mckinley Capital Management Inc increased Evertec Inc (NYSE:EVTC) stake by 47,379 shares to 343,027 valued at $4.68 million in 2017Q4. It also upped Abbvie Inc (NYSE:ABBV) stake by 94,985 shares and now owns 333,657 shares. Juno Therapeutics Inc (NASDAQ:JUNO) was raised too.

More important recent AstraZeneca PLC (NYSE:AZN) news were published by: Bizjournals.com which released: “Why Big Pharma is finally discovering the Bay Area” on May 23, 2018, also Seekingalpha.com published article titled: “FDA’s OKs AstraZeneca’s Lokelma for hyperkalemia”, Investingnews.com published: “IMFINZI (Durvalumab) Significantly Improves Overall Survival in the Phase III Pacific Trial for Unresectable Stage III …” on May 25, 2018. More interesting news about AstraZeneca PLC (NYSE:AZN) was released by: Seekingalpha.com and their article: “Wall Street Breakfast: New Privacy Bar With GDPR” with publication date: May 25, 2018.

Freeport-McMoRan Inc. (NYSE:FCX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Stephen Andrade

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: